Indiana Univ/Melvin and Bren Simon Cancer Center — Indianapolis, Indiana

Indiana Univ/Melvin and Bren Simon Cancer Center is a clinical research site located in Indianapolis, Indiana, United States 46202.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Indiana Univ/Melvin and Bren Simon Cancer Center has participated in 2 clinical trials with 1 currently active.

Therapeutic areas: Metastatic Melanoma, Retroperitoneal Sarcoma, Liposarcoma.

Sponsors: Infinity Pharmaceuticals, Inc., European Organisation for Research and Treatment of Cancer - EORTC.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Indianapolis

Browse all research sites in Indiana · View every site in Indianapolis

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Indiana Univ/Melvin and Bren Simon Cancer Center?

Indiana Univ/Melvin and Bren Simon Cancer Center has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Indiana Univ/Melvin and Bren Simon Cancer Center conducted?

Indiana Univ/Melvin and Bren Simon Cancer Center has 2 clinical trials on record, with 1 currently active. Their work covers Metastatic Melanoma, Retroperitoneal Sarcoma, Liposarcoma.

Is Indiana Univ/Melvin and Bren Simon Cancer Center accredited by Crixeo Clinical Trials?

Indiana Univ/Melvin and Bren Simon Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Indiana Univ/Melvin and Bren Simon Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.